000			01625nam a22003134i 4500
999			_c9531 _d9531
001			9531
003			ES-VaUE
005			20210511161554.0
006			a||||fo|||| 00| 0
007			cr cn |||mnn||
008			201214s2020 ||||| |||| 00| 0 eng d
020			_a978-3-030-50287-4
040			_bspa _cUEV _dES-VaUE
050			_aRC268.3 _b.C36 2021 EB
245			_aCancer Immunology : _bBench to Bedside Immunotherapy of Cancers _cNima Rezaei (editor)
250			_a2nd ed. 2021
260			_aCham _bSpringer Nature Switzerland AG _c2021
300			_a1 recurso en línea
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
520			_aThis translational, clinically oriented book describes in detail novel approaches to cancer immunotherapy, current strategies to target tumor immunosuppression, and prognostic biomarkers for personalized cancer treatments. Since the first, very successful edition of the book was published in 2015, the original chapters have been significantly updated and entirely new chapters are included on, for example, cancer immunoprevention, aptamer-mediated cancer gene therapy, haploidentical bone marrow transplantation for pediatric malignancies, and nanoimmunotherapy.
650		7	_2embne _98412 _aHematología
650		0	_9516571 _aOncología
700			_9516572 _aRezaei, Nima
856	4	0	_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-50287-4
942			_2lcc _cLE
998			_db